[2023]Guideline on treating community-acquired pneumonia with Chinese patent medicines

2024-02-26  点击:[]


上一条:[2023]Maintenance of airway epithelial barrier integrity via the inhibition of AHR/EGFR activation ameliorates chronic obstructive pulmonary disease using effective-component combination.

下一条:[2023]Targeting biophysical microenvironment for improved treatment of chronic obstructive pulmonary disease

关闭

河南中医药大学版权所有 ©2012 Henan University of Chinese Medicine
地址:郑州市金水东路156号 邮编:450046  电话:86-371-65945879
豫ICP备05002492号-1